Safety of a Triple-chamber Bag Parenteral Nutrition in Children Ages up to 24 Months: An Observational Study

OBJECTIVES: Hypermagnesemia has been reported in preterm neonates treated with commercial pediatric triple-chamber bag (3CB) parenteral nutrition (PN). This postmarketing study was requested by the European Medicines Agency to assess the safety of a 3CB PN product in full-term neonates and children...

Descripción completa

Detalles Bibliográficos
Autores principales: Arnell, Henrik, Valla, Frederic V., Malfilâtre, Geneviève, Pladys, Patrick, Senterre, Thibault, Pontes-Arruda, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Original Articles: Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882531/
https://www.ncbi.nlm.nih.gov/pubmed/31567786
http://dx.doi.org/10.1097/MPG.0000000000002512

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6882531/
https://www.ncbi.nlm.nih.gov/pubmed/31567786
http://dx.doi.org/10.1097/MPG.0000000000002512

Ejemplares similares